Mobile Site ›

Risk Stratification in Chronic Lymphocytic Leukemia

The Role of the Clinical Laboratory

Bacterial Antigen Test (BAT)

Slide 22

November 2008

CD49d has two established clinical roles. One is actually as a therapeutic agent. Anti-CD49d has been available as a therapeutic agent for patients with multiple sclerosis and inflammatory bowel disease. Clinical trials are ongoing for using anti-CD49d in various hematologic disorders.

For the purpose of this talk, it should be noted that CD49d is gaining momentum as a prognostic marker in patients with CLL.

CD49d: Clinical Role


Jump to section: